Acute psychosis and serotonin syndrome in the setting of “Triple-C” overdose: a case report

Abstract Background Over-the-counter medication overdose is a difficult diagnostic challenge for many physicians as common drug screening assays cannot detect these substances. We present a case of acute psychosis, serotonin syndrome, and anticholinergic overdose-like properties in the setting of Co...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Roudi Bachar, John Robert Majewski, Christopher Shrack, Anthony El-Khoury
Formato: article
Lenguaje:EN
Publicado: BMC 2021
Materias:
R
Acceso en línea:https://doaj.org/article/e1e010e5294e40acb22a4cd0f813b9fe
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e1e010e5294e40acb22a4cd0f813b9fe
record_format dspace
spelling oai:doaj.org-article:e1e010e5294e40acb22a4cd0f813b9fe2021-11-08T11:13:56ZAcute psychosis and serotonin syndrome in the setting of “Triple-C” overdose: a case report10.1186/s13256-021-03163-z1752-1947https://doaj.org/article/e1e010e5294e40acb22a4cd0f813b9fe2021-11-01T00:00:00Zhttps://doi.org/10.1186/s13256-021-03163-zhttps://doaj.org/toc/1752-1947Abstract Background Over-the-counter medication overdose is a difficult diagnostic challenge for many physicians as common drug screening assays cannot detect these substances. We present a case of acute psychosis, serotonin syndrome, and anticholinergic overdose-like properties in the setting of Coricidin HBP Cough & Cold tablets, known by their street name Triple-C. This is the first case report we are aware of involving a patient presenting with these symptoms and requiring critical-care-level support. Case presentation A 31-year-old African American female with a past medical history of anxiety, childhood asthma, previous methamphetamine abuse, and coronavirus disease 2019 infection in August 2020 was brought to the emergency department by the local police department with altered mental status. Initial blood work, including extended drug screens, were unremarkable for a definitive diagnosis. This patient required critical-care-level support and high sedation because of her symptoms. Collateral history revealed the patient regularly consumed Triple-C daily for the 6 weeks prior to admission. A trial off sedation was attempted after 24 hours with no complications. The patient admitted to regular Triple-C consumption and auditory hallucinations since adolescence. She was discharged safely after 48 hours back into the community. She was lost to follow-up with psychiatry and internal medicine; however, she was evaluated in the emergency room 1 month later with a similar psychiatric presentation. Conclusion Overdose of Triple-C should be kept in the differential diagnosis of patients presenting with a triad of psychosis, serotonin syndrome, and anticholinergic overdose, in the setting of unknown substance ingestion.Roudi BacharJohn Robert MajewskiChristopher ShrackAnthony El-KhouryBMCarticleOverdoseDextromethorphan hydrobromideSerotonin syndromePsychosisMedicineRENJournal of Medical Case Reports, Vol 15, Iss 1, Pp 1-4 (2021)
institution DOAJ
collection DOAJ
language EN
topic Overdose
Dextromethorphan hydrobromide
Serotonin syndrome
Psychosis
Medicine
R
spellingShingle Overdose
Dextromethorphan hydrobromide
Serotonin syndrome
Psychosis
Medicine
R
Roudi Bachar
John Robert Majewski
Christopher Shrack
Anthony El-Khoury
Acute psychosis and serotonin syndrome in the setting of “Triple-C” overdose: a case report
description Abstract Background Over-the-counter medication overdose is a difficult diagnostic challenge for many physicians as common drug screening assays cannot detect these substances. We present a case of acute psychosis, serotonin syndrome, and anticholinergic overdose-like properties in the setting of Coricidin HBP Cough & Cold tablets, known by their street name Triple-C. This is the first case report we are aware of involving a patient presenting with these symptoms and requiring critical-care-level support. Case presentation A 31-year-old African American female with a past medical history of anxiety, childhood asthma, previous methamphetamine abuse, and coronavirus disease 2019 infection in August 2020 was brought to the emergency department by the local police department with altered mental status. Initial blood work, including extended drug screens, were unremarkable for a definitive diagnosis. This patient required critical-care-level support and high sedation because of her symptoms. Collateral history revealed the patient regularly consumed Triple-C daily for the 6 weeks prior to admission. A trial off sedation was attempted after 24 hours with no complications. The patient admitted to regular Triple-C consumption and auditory hallucinations since adolescence. She was discharged safely after 48 hours back into the community. She was lost to follow-up with psychiatry and internal medicine; however, she was evaluated in the emergency room 1 month later with a similar psychiatric presentation. Conclusion Overdose of Triple-C should be kept in the differential diagnosis of patients presenting with a triad of psychosis, serotonin syndrome, and anticholinergic overdose, in the setting of unknown substance ingestion.
format article
author Roudi Bachar
John Robert Majewski
Christopher Shrack
Anthony El-Khoury
author_facet Roudi Bachar
John Robert Majewski
Christopher Shrack
Anthony El-Khoury
author_sort Roudi Bachar
title Acute psychosis and serotonin syndrome in the setting of “Triple-C” overdose: a case report
title_short Acute psychosis and serotonin syndrome in the setting of “Triple-C” overdose: a case report
title_full Acute psychosis and serotonin syndrome in the setting of “Triple-C” overdose: a case report
title_fullStr Acute psychosis and serotonin syndrome in the setting of “Triple-C” overdose: a case report
title_full_unstemmed Acute psychosis and serotonin syndrome in the setting of “Triple-C” overdose: a case report
title_sort acute psychosis and serotonin syndrome in the setting of “triple-c” overdose: a case report
publisher BMC
publishDate 2021
url https://doaj.org/article/e1e010e5294e40acb22a4cd0f813b9fe
work_keys_str_mv AT roudibachar acutepsychosisandserotoninsyndromeinthesettingoftriplecoverdoseacasereport
AT johnrobertmajewski acutepsychosisandserotoninsyndromeinthesettingoftriplecoverdoseacasereport
AT christophershrack acutepsychosisandserotoninsyndromeinthesettingoftriplecoverdoseacasereport
AT anthonyelkhoury acutepsychosisandserotoninsyndromeinthesettingoftriplecoverdoseacasereport
_version_ 1718442384140795904